Literature DB >> 34608281

The interplay of immunology and cachexia in infection and cancer.

Hatoon Baazim1,2,3, Laura Antonio-Herrera1, Andreas Bergthaler4.   

Abstract

Diverse inflammatory diseases, infections and malignancies are associated with wasting syndromes. In many of these conditions, the standards for diagnosis and treatment are lacking due to our limited understanding of the causative molecular mechanisms. Here, we discuss the complex immunological context of cachexia, a systemic catabolic syndrome that depletes both fat and muscle mass with profound consequences for patient prognosis. We highlight the main cytokine and immune cell-driven pathways that have been linked to weight loss and tissue wasting in the context of cancer-associated and infection-associated cachexia. Moreover, we discuss the potential immunometabolic consequences of cachexia on the basis of newly identified pathways and explore the multilayered area of immunometabolic crosstalk both upstream and downstream of tissue catabolism. Collectively, this Review highlights the intricate relationship of the immune system with cachexia in the context of malignant and infectious diseases.
© 2021. Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34608281      PMCID: PMC8489366          DOI: 10.1038/s41577-021-00624-w

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   108.555


  157 in total

Review 1.  Regulation of IL-4 Expression in Immunity and Diseases.

Authors:  I-Cheng Ho; Shi-Chuen Miaw
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

2.  The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi.

Authors:  C Truyens; F Torrico; R Lucas; P De Baetselier; W A Buurman; Y Carlier
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 3.  Immune control by amino acid catabolism during tumorigenesis and therapy.

Authors:  Henrique Lemos; Lei Huang; George C Prendergast; Andrew L Mellor
Journal:  Nat Rev Cancer       Date:  2019-03       Impact factor: 60.716

4.  Tumor inoculation site affects the development of cancer cachexia and muscle wasting.

Authors:  Tatsuzo Matsuyama; Takeshi Ishikawa; Tetsuya Okayama; Kaname Oka; Satoko Adachi; Katsura Mizushima; Reiko Kimura; Manabu Okajima; Hiromi Sakai; Naoyuki Sakamoto; Kazuhiro Katada; Kazuhiro Kamada; Kazuhiko Uchiyama; Osamu Handa; Tomohisa Takagi; Satoshi Kokura; Yuji Naito; Yoshito Itoh
Journal:  Int J Cancer       Date:  2015-06-10       Impact factor: 7.396

5.  Persistent LCMV infection is controlled by blockade of type I interferon signaling.

Authors:  John R Teijaro; Cherie Ng; Andrew M Lee; Brian M Sullivan; Kathleen C F Sheehan; Megan Welch; Robert D Schreiber; Juan Carlos de la Torre; Michael B A Oldstone
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

6.  Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis.

Authors:  Aaron W B Joe; Lin Yi; Anuradha Natarajan; Fabien Le Grand; Leslie So; Joy Wang; Michael A Rudnicki; Fabio M V Rossi
Journal:  Nat Cell Biol       Date:  2010-01-17       Impact factor: 28.824

7.  Microglia in the hypothalamus respond to tumor-derived factors and are protective against cachexia during pancreatic cancer.

Authors:  Kevin G Burfeind; Xinxia Zhu; Mason A Norgard; Peter R Levasseur; Christian Huisman; Katherine A Michaelis; Brennan Olson; Daniel L Marks
Journal:  Glia       Date:  2020-02-10       Impact factor: 7.452

8.  Toll-Like Receptor-4 Disruption Suppresses Adipose Tissue Remodeling and Increases Survival in Cancer Cachexia Syndrome.

Authors:  Felipe Henriques; Magno A Lopes; Felipe O Franco; Pamela Knobl; Kaltinaitis B Santos; Luana L Bueno; Victor A Correa; Alexander H Bedard; Adilson Guilherme; Alexander Birbrair; Sidney B Peres; Stephen R Farmer; Miguel L Batista
Journal:  Sci Rep       Date:  2018-12-21       Impact factor: 4.379

9.  Modeling Human Cancer-induced Cachexia.

Authors:  Erin E Talbert; Maria C Cuitiño; Katherine J Ladner; Priyani V Rajasekerea; Melissa Siebert; Reena Shakya; Gustavo W Leone; Michael C Ostrowski; Brian Paleo; Noah Weisleder; Peter J Reiser; Amy Webb; Cynthia D Timmers; Daniel S Eiferman; David C Evans; Mary E Dillhoff; Carl R Schmidt; Denis C Guttridge
Journal:  Cell Rep       Date:  2019-08-06       Impact factor: 9.423

10.  An elevated neutrophil-to-lymphocyte ratio associates with weight loss and cachexia in cancer.

Authors:  Tyler Barker; Gail Fulde; Bryce Moulton; Lincoln D Nadauld; Terence Rhodes
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.379

View more
  12 in total

Review 1.  Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer.

Authors:  Anja Karlstaedt; Javid Moslehi; Rudolf A de Boer
Journal:  Nat Rev Cardiol       Date:  2022-04-19       Impact factor: 32.419

2.  Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer.

Authors:  Robert H Shoemaker; Reynold A Panettieri; Steven K Libutti; Howard S Hochster; Norman R Watts; Paul T Wingfield; Philipp Starkl; Lisabeth Pimenov; Riem Gawish; Anastasiya Hladik; Sylvia Knapp; Daniel Boring; Jonathan M White; Quentin Lawrence; Jeremy Boone; Jason D Marshall; Rebecca L Matthews; Brian D Cholewa; Jeffrey W Richig; Ben T Chen; David L McCormick; Romana Gugensberger; Sonja Höller; Josef M Penninger; Gerald Wirnsberger
Journal:  PLoS One       Date:  2022-07-11       Impact factor: 3.752

Review 3.  Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia.

Authors:  Bahar Zehra Camurdanoglu Weber; Dilsad H Arabaci; Serkan Kir
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

Review 4.  Molecular Mechanisms and Current Treatment Options for Cancer Cachexia.

Authors:  Syed Sayeed Ahmad; Khurshid Ahmad; Sibhghatulla Shaikh; Hye Jin You; Eun-Young Lee; Shahid Ali; Eun Ju Lee; Inho Choi
Journal:  Cancers (Basel)       Date:  2022-04-23       Impact factor: 6.575

5.  ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology.

Authors:  Riem Gawish; Philipp Starkl; Lisabeth Pimenov; Anastasiya Hladik; Karin Lakovits; Felicitas Oberndorfer; Shane Jf Cronin; Anna Ohradanova-Repic; Gerald Wirnsberger; Benedikt Agerer; Lukas Endler; Tümay Capraz; Jan W Perthold; Domagoj Cikes; Rubina Koglgruber; Astrid Hagelkruys; Nuria Montserrat; Ali Mirazimi; Louis Boon; Hannes Stockinger; Andreas Bergthaler; Chris Oostenbrink; Josef M Penninger; Sylvia Knapp
Journal:  Elife       Date:  2022-01-13       Impact factor: 8.140

Review 6.  Cytokines and Chemokines in Cancer Cachexia and Its Long-Term Impact on COVID-19.

Authors:  Santosh Kumar Singh; Rajesh Singh
Journal:  Cells       Date:  2022-02-08       Impact factor: 6.600

7.  Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.

Authors:  Xiaoling Zhong; Ashok Narasimhan; Libbie M Silverman; Andrew R Young; Safi Shahda; Sheng Liu; Jun Wan; Yunlong Liu; Leonidas G Koniaris; Teresa A Zimmers
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-05-05       Impact factor: 12.063

Review 8.  The evolving view of thermogenic fat and its implications in cancer and metabolic diseases.

Authors:  Xinpeng Yin; Yuan Chen; Rexiati Ruze; Ruiyuan Xu; Jianlu Song; Chengcheng Wang; Qiang Xu
Journal:  Signal Transduct Target Ther       Date:  2022-09-16

Review 9.  Tumor accomplice: T cell exhaustion induced by chronic inflammation.

Authors:  Liguang Fang; Kunjing Liu; Cun Liu; Xiaomin Wang; Wenzhe Ma; Wenhua Xu; Jibiao Wu; Changgang Sun
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

Review 10.  Cancer cachexia as a multiorgan failure: Reconstruction of the crime scene.

Authors:  Michele Ferrara; Maria Samaden; Elena Ruggieri; Emilie Vénéreau
Journal:  Front Cell Dev Biol       Date:  2022-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.